Lv3
210 积分 2025-07-08 加入
Cagrilintide–Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes
9天前
已关闭
Cagrilintide–Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes
9天前
已关闭
代谢正常型肥胖的新认识及其研究机遇
1个月前
已完结
代谢正常型肥胖的新认识及其研究机遇
1个月前
已关闭
健康体重 健康生活
1个月前
已完结
Efficacy and safety of a biased GLP-1 receptor agonist ecnoglutide in adults with overweight or obesity: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
1个月前
已完结
皖公网安备34019202002308
